ghk-cu copper peptide skin clinical study for Skin: What the Evidence Shows MICC | Weight Management Specification:20 mg New

ghk-cu copper peptide skin clinical study for Skin: What the Evidence Shows MICC | Weight Management Specification:20 mg New

MICC | Weight Management Injection | Olympia Pharmaceuticals

Important Notice These products are: Not approved for human consumption Not approved for diagnostic or therapeutic use Not intended for medical application Intended strictly for controlled laboratory research Researchers should use peptide materials only within lawful laboratory environments

New

Specification:20 mg

A common titration approach includes: Week 1–2: 0.3 mg Week 3–4: 0.6 mg Week 5–6: 1.2 mg Week 7–8: 1.8 mg Week 9 and onward: 2.4 mg or higher, based on tolerance and clinical response ⚠️ Always consult a healthcare provider or licensed research facility for actual dosing guidance